Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-453
Closed -$40.8K 1243
2025
Q3
$40.8K Buy
453
+9
+2% +$729 0.01% 298
2025
Q2
$33.6K Buy
444
+4
+0.9% +$297 0.01% 312
2025
Q1
$31.4K Buy
440
+96
+28% +$7.48K 0.01% 317
2024
Q4
$30.2K Buy
344
+2
+0.6% +$175 0.01% 387
2024
Q3
$28.6K Buy
342
+3
+0.9% +$240 0.01% 440
2024
Q2
$25.8K Buy
339
+3
+0.9% +$222 0.01% 459
2024
Q1
$24.1K Buy
+336
New +$24.1K 0.01% 513
2023
Q2
Sell
-76
Closed -$5.73K 790
2023
Q1
$5.73K Hold
76
﹤0.01% 435
2022
Q4
$5.82K Buy
76
+2
+3% +$155 ﹤0.01% 426
2022
Q3
$6K Hold
74
0.01% 423
2022
Q2
$6K Hold
74
0.01% 422
2022
Q1
$6K Hold
74
0.01% 403
2021
Q4
$4.83K Buy
+74
New +$4.69K ﹤0.01% 406

Other funds holding SRE

Rise Advisors's SRE Position: Q4 2025 in Review

Rise Advisors sold out of Sempra (SRE) in Q4 2025, closing a stake of 453 shares — an estimated $40.8K sold.

Rise Advisors first reported a position in SRE in Q4 2021 and held it in 13 quarters. The position peaked at $40.8K in Q3 2025. 1,210 funds tracked by Wall St. Rank hold SRE as of Q4 2025.

  • Rise Advisors reported no remaining Sempra position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 453 Sempra shares in Q4 2025, an estimated $40.8K.
  • Rise Advisors first reported a position in Sempra in Q4 2021 and held it in 13 quarters.
  • Rise Advisors's Sempra position peaked at $40.8K in Q3 2025.
  • 1,210 funds tracked by Wall St. Rank held Sempra as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.